Cargando…
Tocilizumab: Hepatitis-B viral reactivation with acute hepatitis following an off-label treatment: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642184/ http://dx.doi.org/10.1007/s40278-021-06730-0 |
Ejemplares similares
-
Glucocorticoids/siltuximab/tocilizumab: Hepatitis-B reactivation following off-label use: 2 case reports
Publicado: (2021) -
Tocilizumab: Cytomegalovirus reactivation and acute hepatitis: case report
Publicado: (2021) -
Dexamethasone/tocilizumab: Worsening of hepatitis E virus infection following off label use: case report
Publicado: (2022) -
Corticosteroids/tocilizumab: Reactivation of Mycobacterium tuberculosis following off-label therapy: case report
Publicado: (2020) -
Entecavir/interferon-α-2b/methylprednisolone: Hepatitis B viral reactivation and off label use: case report
Publicado: (2021)